http://www.mydailyapple.com/news_alert/topfeed/thu 2009-11-19T07:00:21Z tag:praxeon.com,2007:s3%3Ahttp%253A%2F%2Ffeeds.feedburner.com%2FXconomy_Full%3Ahttp%3A%2F%2Fwww.xconomy.com%2F%3Fp%3D50780 2009-11-19T07:00:21Z http://feeds.feedburner.com/Xconomy_Full

<p>Google, Yahoo, Facebook, MySpace. Those companies&#8217; products spread over the Internet like a virus. But why hasn&#8217;t there been a runaway hit like those in the mobile software world? Why does it take so much longer to build value, and a strong customer base, in mobile companies than in certain Internet startups? Dan Shapiro had some [...] <br clear="both" style="clear: both;" /> <br clear="both" style="clear: both;" /> <a href="http://ads.pheedo.com/click.phdo?s=b010770a8af8dfad0ca0bdc6ce092e9d&amp;p=1"> <img alt="" style="border: 0;" border="0" src="http://ads.pheedo.com/img.phdo?s=b010770a8af8dfad0ca0bdc6ce092e9d&amp;p=1" /> </a> <img alt="" height="0" width="0" border="0" style="display:none" src="http://a.rfihub.com/eus.gif?eui=2218" /></p>

<p>Google, Yahoo, Facebook, MySpace. Those companies&#8217; products spread over the Internet like a virus. But why hasn&#8217;t there been a runaway hit like those in the mobile software world? Why does it take so much longer to build value, and a strong customer base, in mobile companies than in certain Internet startups? Dan Shapiro had some [...] <br clear="both" style="clear: both;" /> <br clear="both" style="clear: both;" /> <a href="http://ads.pheedo.com/click.phdo?s=b010770a8af8dfad0ca0bdc6ce092e9d&amp;p=1"> <img alt="" style="border: 0;" border="0" src="http://ads.pheedo.com/img.phdo?s=b010770a8af8dfad0ca0bdc6ce092e9d&amp;p=1" /> </a> <img alt="" height="0" width="0" border="0" style="display:none" src="http://a.rfihub.com/eus.gif?eui=2218" /></p> tag:praxeon.com,2007:s3%3Ahttp%253A%2F%2Fz.about.com%2F6%2Fg%2Fheadaches%2Fb%2Frss2.xml%3Ahttp%3A%2F%2Fheadaches.about.com%2Fb%2F2009%2F11%2F11%2Fathletes-with-migraines.htm 2009-11-19T07:00:21Z http://z.about.com/6/g/headaches/b/rss2.xml

<p><p>Migraine headaches strike all types of individuals in all types of professions. <a href="http://clk.about.com/?zi=1/1hc&amp;zu=http://www.buffalobills.com/news/article-3/Migraines-gone-for-Nelson/4ddadc93-2a8c-40b1-acac-6de0fa05a49e">Shawn Nelson, rookie tight end for the National Football League's Buffalo Bills</a>, has recently been dealing with a bout of migraine headaches but is finding a way to stay active with his team. Nelson injured his neck blocking in a game a few weeks ago and feels like this was the most recent trigger, but he has suffered from migraines for at least the last 10 years. His mother was also a migraine sufferer</p> <p>Nelson spoke a little bit about what it feels like to have a migraine, and how athleticism and size are no guarantees for good health:</p> <blockquote>Some people get injuries and some people's bodies react in different ways. From the outside looking in some players' afflictions look really small. But you won't know unless you've had migraines yourself, especially the way I get them. They are unreal. I can't even move.</blockquote>This just underscores the fact that migraines can strike anyone and can be debilitating no matter what that person's overall health may be like. <br /> <br /> <p>What other <a href="http://clk.about.com/?zi=1/1hc&amp;zu=http://headaches.about.com/od/headaches101/a/triggers.htm">headache triggers</a> are out there?</p> <p>Many NFL players experience <a href="http://clk.about.com/?zi=1/1hc&amp;zu=http://headaches.about.com/od/isitamigraine/a/concussion.htm">concussions</a>, which can be a secondary cause for headaches.</p> <p style="text-align: center;">============================= <br /> To keep up on useful information <br /> related to headaches and migraines, <br /> subscribe to the <br /> <a href="http://clk.about.com/?zi=1/1hc&amp;zu=http://headaches.about.com/gi/pages/stay.htm">Headaches and Migraines Newsletter</a>. <br /> =============================</p> <p style="background:#f5f3ef;border: 1px solid #d5d0bf;padding:.5em;"> <a href="http://clk.about.com/?zi=1/1hc&amp;zu=http://headaches.about.com/b/2009/11/11/athletes-with-migraines.htm">Athletes with Migraines</a> originally appeared on <a href="http://clk.about.com/?zi=1/1hc&amp;zu=http://headaches.about.com/">About.com Headaches / Migraine</a> on Wednesday, November 11th, 2009 at 08:53:57.</p> <p> <a href="http://clk.about.com/?zi=1/1hc&amp;zu=http://headaches.about.com/b/2009/11/11/athletes-with-migraines.htm">Permalink</a> | <a href="http://clk.about.com/?zi=1/1hc&amp;zu=http://headaches.about.com/b/2009/11/11/athletes-with-migraines.htm#gB3">Comment</a> | <a href="http://headaches.about.com/gi/pages/shareurl.htm?PG=http://headaches.about.com/b/2009/11/11/athletes-with-migraines.htm&amp;zItl=Athletes%20with%20Migraines">Email this</a></p></p>

<p><p>Migraine headaches strike all types of individuals in all types of professions. <a href="http://clk.about.com/?zi=1/1hc&amp;zu=http://www.buffalobills.com/news/article-3/Migraines-gone-for-Nelson/4ddadc93-2a8c-40b1-acac-6de0fa05a49e">Shawn Nelson, rookie tight end for the National Football League's Buffalo Bills</a>, has recently been dealing with a bout of migraine headaches but is finding a way to stay active with his team. Nelson injured his neck blocking in a game a few weeks ago and feels like this was the most recent trigger, but he has suffered from migraines for at least the last 10 years. His mother was also a migraine sufferer</p> <p>Nelson spoke a little bit about what it feels like to have a migraine, and how athleticism and size are no guarantees for good health:</p> <blockquote>Some people get injuries and some people's bodies react in different ways. From the outside looking in some players' afflictions look really small. But you won't know unless you've had migraines yourself, especially the way I get them. They are unreal. I can't even move.</blockquote>This just underscores the fact that migraines can strike anyone and can be debilitating no matter what that person's overall health may be like. <br /> <br /> <p>What other <a href="http://clk.about.com/?zi=1/1hc&amp;zu=http://headaches.about.com/od/headaches101/a/triggers.htm">headache triggers</a> are out there?</p> <p>Many NFL players experience <a href="http://clk.about.com/?zi=1/1hc&amp;zu=http://headaches.about.com/od/isitamigraine/a/concussion.htm">concussions</a>, which can be a secondary cause for headaches.</p> <p style="text-align: center;">============================= <br /> To keep up on useful information <br /> related to headaches and migraines, <br /> subscribe to the <br /> <a href="http://clk.about.com/?zi=1/1hc&amp;zu=http://headaches.about.com/gi/pages/stay.htm">Headaches and Migraines Newsletter</a>. <br /> =============================</p> <p style="background:#f5f3ef;border: 1px solid #d5d0bf;padding:.5em;"> <a href="http://clk.about.com/?zi=1/1hc&amp;zu=http://headaches.about.com/b/2009/11/11/athletes-with-migraines.htm">Athletes with Migraines</a> originally appeared on <a href="http://clk.about.com/?zi=1/1hc&amp;zu=http://headaches.about.com/">About.com Headaches / Migraine</a> on Wednesday, November 11th, 2009 at 08:53:57.</p> <p> <a href="http://clk.about.com/?zi=1/1hc&amp;zu=http://headaches.about.com/b/2009/11/11/athletes-with-migraines.htm">Permalink</a> | <a href="http://clk.about.com/?zi=1/1hc&amp;zu=http://headaches.about.com/b/2009/11/11/athletes-with-migraines.htm#gB3">Comment</a> | <a href="http://headaches.about.com/gi/pages/shareurl.htm?PG=http://headaches.about.com/b/2009/11/11/athletes-with-migraines.htm&amp;zItl=Athletes%20with%20Migraines">Email this</a></p></p> tag:praxeon.com,2007:s3%3Ahttp%253A%2F%2Fwww.sciencedaily.com%2Frss%2Fhealth_medicine.xml%3A%2Freleases%2F2009%2F11%2F091110090905.htm 2009-11-19T07:00:21Z http://www.sciencedaily.com/rss/health_medicine.xml

<p>The drug Sprycel, approved for use by the US Food and Drug Administration in patients with chronic myeloid leukemia, significantly inhibited the growth and invasiveness of ovarian cancer cells and also promoted their death, a new study has found.</p>

<p>The drug Sprycel, approved for use by the US Food and Drug Administration in patients with chronic myeloid leukemia, significantly inhibited the growth and invasiveness of ovarian cancer cells and also promoted their death, a new study has found.</p> tag:praxeon.com,2007:s3%3Ahttp%253A%2F%2Fwww.medworm.com%2Frss%2Fmedicalfeeds%2Fspecialities%2FConsumer-Health-News.xml%3A2977820 2009-11-19T07:00:21Z http://www.medworm.com/rss/medicalfeeds/specialities/Consumer-Health-News.xml

<p>The US Food and Drug Administration has granted orphan drug designation for voreloxin in the treatment of acute myeloid leukemia. Medscape Medical News (Source: Medscape Today Headlines)</p>

<p>The US Food and Drug Administration has granted orphan drug designation for voreloxin in the treatment of acute myeloid leukemia. Medscape Medical News (Source: Medscape Today Headlines)</p> tag:praxeon.com,2007:s3%3Ahttp%253A%2F%2Fwww.sciencedaily.com%2Frss%2Fhealth_medicine.xml%3A%2Freleases%2F2009%2F10%2F091029211647.htm 2009-11-12T07:01:26Z http://www.sciencedaily.com/rss/health_medicine.xml

<p>Simvastatin, a commonly used, cholesterol-lowering drug, may prevent Parkinson's disease from progressing further. Neurological researchers conducted a study examining the use of the FDA-approved medication in mice with Parkinson's disease and found that the drug successfully reverses the biochemical, cellular and anatomical changes caused by the disease.</p>

<p>Simvastatin, a commonly used, cholesterol-lowering drug, may prevent Parkinson's disease from progressing further. Neurological researchers conducted a study examining the use of the FDA-approved medication in mice with Parkinson's disease and found that the drug successfully reverses the biochemical, cellular and anatomical changes caused by the disease.</p> tag:praxeon.com,2007:s3%3Ahttp%253A%2F%2Fwww.generef.com%2Frss%2Fall.news.xml%3Ahttp%3A%2F%2Fgeneref.com%2Fnewsstory.rss.html%3Fpid%3D72895 2009-11-12T07:01:26Z http://www.generef.com/rss/all.news.xml

<p>The small-molecule inhibitor nutlin-3 may be a viable treatment option for neuroblastoma patients with wild-type p53 activity, according to a new study published online Nov. 10 in the Journal of the National Cancer Institute.</p>

<p>The small-molecule inhibitor nutlin-3 may be a viable treatment option for neuroblastoma patients with wild-type p53 activity, according to a new study published online Nov. 10 in the Journal of the National Cancer Institute.</p> tag:praxeon.com,2007:s3%3Ahttp%253A%2F%2Fwww.neurology.org%3Ahttp%3A%2F%2Fwww.neurology.org%2Fcgi%2Fcontent%2Fshort%2F73%2F19%2F1584%3Frss%3D1 2009-11-12T07:01:26Z http://www.neurology.org

<p><p> <b>Background:</b> Nonmotor symptoms (NMS) have a great impact on patients with Parkinson disease (PD). The Non-Motor Symptoms Scale (NMSS) is an instrument specifically designed for the comprehensive assessment of NMS in patients with PD. NMSS psychometric properties have been tested in this study.</p> <p> <b>Methods:</b> Data were collected in 12 centers across 10 countries in America, Asia, and Europe. In addition to the NMSS, the following measures were applied: Scales for Outcomes in Parkinson&#8217;s Disease (SCOPA)-Motor, SCOPA-Psychiatric Complications (SCOPA-PC), SCOPA-Cognition, Hoehn and Yahr Staging (HY), Clinical Impression of Severity Index for Parkinson&#8217;s Disease (CISI-PD), SCOPA-Autonomic, Parkinson&#8217;s Disease Sleep Scale (PDSS), Parkinson&#8217;s Disease Questionnaire&#8211;39 items (PDQ-39), and EuroQol&#8211;5 dimensions (EQ-5D). NMSS acceptability, reliability, validity, and precision were analyzed.</p> <p> <b>Results:</b> Four hundred eleven patients with PD, 61.3% men, were recruited. The mean age was 64.5 ± 9.9 years, and mean disease duration was 8.1 ± 5.7 years. The NMSS score was 57.1 ± 44.0 points. The scale was free of floor or ceiling effects. For domains, the Cronbach coefficient ranged from 0.44 to 0.85. The intraclass correlation coefficient (0.90 for the total score, 0.67&#8211;0.91 for domains) and Lin concordance coefficient (0.88) suggested satisfactory reproducibility. The NMSS total score correlated significantly with SCOPA-Autonomic, PDQ-39, and EQ-5D ( <i>r</i> _S = 0.57&#8211;0.70). Association was close between NMSS domains and the corresponding SCOPA&#8211;Autonomic domains ( <i>r</i> _S = 0.51&#8211;0.65) and also with scales measuring related constructs (PDSS, SCOPA-PC) (all <i>p</i> &lt; 0.0001). The NMSS total score was higher for women ( <i>p</i> &lt; 0.02) and for increasing disease duration, HY, and CISI-PD severity level ( <i>p</i> &lt; 0.001). The SEM was 13.91 for total score and 1.71 to 4.73 for domains.</p> <p> <b>Conclusion:</b> The Non-Motor Symptoms Scale is an acceptable, reproducible, valid, and precise assessment instrument for nonmotor symptoms in Parkinson disease.</p></p>

<p><p> <b>Background:</b> Nonmotor symptoms (NMS) have a great impact on patients with Parkinson disease (PD). The Non-Motor Symptoms Scale (NMSS) is an instrument specifically designed for the comprehensive assessment of NMS in patients with PD. NMSS psychometric properties have been tested in this study.</p> <p> <b>Methods:</b> Data were collected in 12 centers across 10 countries in America, Asia, and Europe. In addition to the NMSS, the following measures were applied: Scales for Outcomes in Parkinson&#8217;s Disease (SCOPA)-Motor, SCOPA-Psychiatric Complications (SCOPA-PC), SCOPA-Cognition, Hoehn and Yahr Staging (HY), Clinical Impression of Severity Index for Parkinson&#8217;s Disease (CISI-PD), SCOPA-Autonomic, Parkinson&#8217;s Disease Sleep Scale (PDSS), Parkinson&#8217;s Disease Questionnaire&#8211;39 items (PDQ-39), and EuroQol&#8211;5 dimensions (EQ-5D). NMSS acceptability, reliability, validity, and precision were analyzed.</p> <p> <b>Results:</b> Four hundred eleven patients with PD, 61.3% men, were recruited. The mean age was 64.5 ± 9.9 years, and mean disease duration was 8.1 ± 5.7 years. The NMSS score was 57.1 ± 44.0 points. The scale was free of floor or ceiling effects. For domains, the Cronbach coefficient ranged from 0.44 to 0.85. The intraclass correlation coefficient (0.90 for the total score, 0.67&#8211;0.91 for domains) and Lin concordance coefficient (0.88) suggested satisfactory reproducibility. The NMSS total score correlated significantly with SCOPA-Autonomic, PDQ-39, and EQ-5D ( <i>r</i> _S = 0.57&#8211;0.70). Association was close between NMSS domains and the corresponding SCOPA&#8211;Autonomic domains ( <i>r</i> _S = 0.51&#8211;0.65) and also with scales measuring related constructs (PDSS, SCOPA-PC) (all <i>p</i> &lt; 0.0001). The NMSS total score was higher for women ( <i>p</i> &lt; 0.02) and for increasing disease duration, HY, and CISI-PD severity level ( <i>p</i> &lt; 0.001). The SEM was 13.91 for total score and 1.71 to 4.73 for domains.</p> <p> <b>Conclusion:</b> The Non-Motor Symptoms Scale is an acceptable, reproducible, valid, and precise assessment instrument for nonmotor symptoms in Parkinson disease.</p></p> tag:praxeon.com,2007:s3%3Ahttp%253A%2F%2Fwww.news-medical.net%2Findex_rss.asp%3Fitems%3D25%3Apost.aspx%3Fid%3Df0279747-ade0-420b-aa85-cea9b508a1b3 2009-11-12T07:01:26Z http://www.news-medical.net/index_rss.asp?items=25

<p>Kineta, Inc. announced today it has been awarded a $6.8 million subcontract from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to develop novel vaccine adjuvants (agents that help boost the immune system). The Kineta subcontract is part of a larger $13 million award to the University of Washington.</p>

<p>Kineta, Inc. announced today it has been awarded a $6.8 million subcontract from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to develop novel vaccine adjuvants (agents that help boost the immune system). The Kineta subcontract is part of a larger $13 million award to the University of Washington.</p> tag:praxeon.com,2007:s3%3Ahttp%253A%2F%2Fchestjournal.chestpubs.org%3Ahttp%3A%2F%2Fchestjournal.chestpubs.org%2Fcgi%2Fcontent%2Fshort%2F136%2F5%2F1420%3Frss%3D1 2009-11-05T07:01:24Z http://chestjournal.chestpubs.org

<p></p>

<p></p> tag:praxeon.com,2007:s3%3Ahttp%253A%2F%2Fchestjournal.chestpubs.org%3Ahttp%3A%2F%2Fchestjournal.chestpubs.org%2Fcgi%2Fcontent%2Fshort%2F136%2F5%2F1193%3Frss%3D1 2009-11-05T07:01:24Z http://chestjournal.chestpubs.org

<p></p>

<p></p> tag:praxeon.com,2007:s3%3Ahttp%253A%2F%2Fwww.generef.com%2Frss%2Fall.news.xml%3Ahttp%3A%2F%2Fgeneref.com%2Fnewsstory.rss.html%3Fpid%3D72687 2009-11-05T07:01:24Z http://www.generef.com/rss/all.news.xml

<p>http://finance.yahoo.com/q?s=yar.ol</p>

<p>http://finance.yahoo.com/q?s=yar.ol</p> tag:praxeon.com,2007:s3%3Ahttp%253A%2F%2Ffeeds.feedburner.com%2Ftime%2Fscienceandhealth%3Ahttp%3A%2F%2Fwww.time.com%2Ftime%2Fhealth%2Farticle%2F0%2C8599%2C1934826%2C00.html%3Fxid%3Drss-health 2009-11-05T07:01:24Z http://feeds.feedburner.com/time/scienceandhealth

<p>Iowa public health officials reported on Wednesday the first confirmed case of H1N1 flu in a house pet: a cat <img src="http://feeds.feedburner.com/~r/time/scienceandhealth/~4/rQmJhqgfexM" height="1" width="1" /></p>

<p>Iowa public health officials reported on Wednesday the first confirmed case of H1N1 flu in a house pet: a cat <img src="http://feeds.feedburner.com/~r/time/scienceandhealth/~4/rQmJhqgfexM" height="1" width="1" /></p>